Chill Brands Group PLC (CHBRF) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Chill Brands Group PLC (CHBRF) opera en el sector Healthcare, cotizado por última vez a $ con una capitalización de mercado de 0. Calificado con 38/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 16 mar 2026Chill Brands Group PLC (CHBRF) Resumen de Asistencia Médica y Tuberías
Chill Brands Group PLC is a UK-based company operating in the cannabidiol (CBD) consumer products market, offering tobacco alternatives and wellness products under the Chill.com and Zoetic brands, facing significant competition and financial challenges in the evolving regulatory landscape of the US, UK, and European markets.
Tesis de Inversión
Investing in Chill Brands Group PLC (CHBRF) presents significant risks due to its negative profitability, as evidenced by a -547.6% profit margin and a -48.1% gross margin. The company operates in a highly competitive and evolving regulatory environment within the CBD market. While the company has a presence in the US, UK, and Europe, its small market capitalization of $0.02 billion and negative P/E ratio of -1.35 indicate financial instability. Growth catalysts depend heavily on successful product launches and expansion into new markets, which are subject to regulatory approvals and market acceptance. The investment thesis hinges on the company's ability to achieve profitability and navigate the complex regulatory landscape, which is uncertain at this time.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $0.02 billion indicates a micro-cap company with high volatility potential.
- Negative profit margin of -547.6% reflects significant operational inefficiencies and challenges in achieving profitability.
- Gross margin of -48.1% suggests the company is selling products at a loss before considering operating expenses.
- The company operates in the rapidly evolving and highly competitive cannabidiol (CBD) market.
- Chill Brands Group PLC changed its name from Zoetic International PLC in August 2021, signaling a strategic shift in branding and market focus.
Competidores y Pares
Fortalezas
- Established brands (Chill.com and Zoetic).
- Presence in multiple geographic markets (US, UK, Europe).
- Diverse product portfolio of CBD-infused products.
Debilidades
- Negative profit margin and gross margin.
- Small market capitalization.
- Limited financial resources.
Catalizadores
- Upcoming: Potential regulatory changes in the US, UK, and Europe regarding CBD products could create new market opportunities or pose additional challenges.
- Ongoing: Expansion of the company's product portfolio with new CBD-infused products targeting specific health and wellness needs.
- Ongoing: Strategic partnerships with established retailers and distributors to expand market reach.
- Ongoing: Increased consumer awareness of the potential health benefits of CBD products.
- Ongoing: Development of a strong online presence and e-commerce platform to drive direct-to-consumer sales.
Riesgos
- Ongoing: Evolving regulatory landscape for CBD products in the US, UK, and Europe.
- Ongoing: Intense competition in the CBD market from established players and new entrants.
- Potential: Fluctuations in consumer demand for CBD products.
- Potential: Negative publicity or adverse health effects associated with CBD products.
- Ongoing: Limited financial resources and negative profitability.
Oportunidades de crecimiento
- Expansion into new geographic markets represents a significant growth opportunity for Chill Brands. The company currently operates in the US, UK, and Europe, but further expansion into other regions with favorable regulatory environments could drive revenue growth. Successfully entering new markets requires significant investment in marketing, distribution, and regulatory compliance, but the potential rewards could be substantial. The global cannabis market is projected to reach $47 billion by 2027, presenting a large addressable market for Chill Brands.
- Development of new CBD-infused products targeting specific health and wellness needs could drive revenue growth and increase market share. Chill Brands currently offers a range of products, including tobacco alternatives, tinctures, and topical creams, but expanding its product portfolio to address specific conditions such as anxiety, sleep disorders, and pain management could attract new customers and increase customer loyalty. This requires investment in research and development, as well as clinical trials to validate the efficacy of new products. The market for CBD-infused health and wellness products is growing rapidly, driven by increasing consumer awareness of potential health benefits.
- Strategic partnerships with established retailers and distributors could significantly expand Chill Brands' market reach and increase brand awareness. Collaborating with major retailers in the US, UK, and Europe could provide access to a large customer base and enhance brand visibility. This requires negotiating favorable terms and ensuring consistent product quality and supply. The retail landscape is evolving rapidly, with increasing demand for CBD products in mainstream retail channels.
- Focus on building a strong online presence and e-commerce platform could drive direct-to-consumer sales and increase brand loyalty. Investing in search engine optimization (SEO), social media marketing, and targeted advertising could attract new customers and increase online sales. This requires building a user-friendly website, offering competitive pricing, and providing excellent customer service. The e-commerce channel is growing rapidly, driven by increasing consumer preference for online shopping.
- Lobbying and advocacy efforts to influence regulatory policies and promote favorable legislation could create a more supportive environment for the CBD industry and benefit Chill Brands. Engaging with policymakers and industry associations to advocate for clear and consistent regulations could reduce uncertainty and create a more level playing field for all companies. This requires investing in government relations and building strong relationships with key stakeholders. The regulatory landscape for CBD is constantly evolving, and proactive engagement with policymakers is essential for long-term success.
Oportunidades
- Expansion into new geographic markets.
- Development of new CBD-infused products.
- Strategic partnerships with established retailers.
Amenazas
- Evolving regulatory landscape for CBD products.
- Intense competition in the CBD market.
- Fluctuations in consumer demand for CBD products.
Ventajas competitivas
- Brand recognition through the Chill.com and Zoetic brands.
- Proprietary formulations and manufacturing processes for CBD products.
- Established distribution network in the US, UK, and Europe.
Acerca de CHBRF
Chill Brands Group PLC, formerly known as Zoetic International PLC, was founded in 2014 and rebranded in August 2021 to reflect its strategic focus on the 'Chill' brand. Headquartered in London, the company operates in the cannabidiol (CBD) consumer products and lifestyle goods sector, with a presence in the United States, the United Kingdom, and Europe. Chill Brands develops, produces, and sells a variety of CBD-infused products, including tobacco alternative products such as smokes and chew pouches, catering to consumers seeking alternatives to traditional tobacco products. The company also offers oral tinctures, soft-gel capsules, massage oils, and topical cosmetic products, targeting the broader wellness market. These products are marketed under the Chill.com and Zoetic brands, with the Chill.com brand representing the company's primary focus. Despite its presence in multiple geographic markets, Chill Brands faces challenges related to regulatory uncertainties and intense competition within the rapidly evolving CBD industry. The company's ability to navigate these challenges and establish a sustainable market position will be critical to its long-term success.
Qué hacen
- Researches and develops cannabidiol (CBD) consumer products.
- Produces a range of CBD-infused products, including tobacco alternatives.
- Sells CBD products in the United States, the United Kingdom, and Europe.
- Offers tobacco alternative products like smokes and chew pouches.
- Provides oral tinctures and soft-gel capsules.
- Manufactures massage oils and topical cosmetic products.
- Markets its products under the Chill.com and Zoetic brands.
Modelo de Negocio
- Develops and manufactures CBD-infused consumer products.
- Sells products through online channels and retail partnerships.
- Generates revenue from the sale of CBD products in the US, UK, and Europe.
Contexto de la Industria
Chill Brands Group PLC operates within the rapidly expanding yet highly fragmented cannabidiol (CBD) market. This market is characterized by evolving regulations, intense competition, and fluctuating consumer demand. The global CBD market is projected to reach billions of dollars in the coming years, driven by increasing consumer awareness of potential health benefits and the legalization of cannabis in various jurisdictions. However, regulatory uncertainties and varying standards across different countries pose significant challenges for companies like Chill Brands. Competitors such as ATHJF (Australis Capital Inc.), BFFTF (BevCanna Enterprises Inc.), EMMLF (Emerald Health Therapeutics Inc.), GENH (General Hemp Corp), and GRAMF (The Gram Co Inc.) are vying for market share, intensifying the competitive landscape.
Clientes Clave
- Consumers seeking alternatives to traditional tobacco products.
- Individuals interested in CBD-infused wellness products.
- Customers in the United States, the United Kingdom, and Europe.
Finanzas
Gráfico e información
Precio de la acción de Chill Brands Group PLC (CHBRF): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para CHBRF.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CHBRF.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para CHBRF.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de CHBRF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Graham John William Duncan
CEO
Graham John William Duncan serves as the CEO of Chill Brands Group PLC, leading a team of 7 employees. His background includes experience in managing and developing consumer product companies, with a focus on strategic growth and market expansion. He has been instrumental in guiding the company through its rebranding and strategic shift towards the 'Chill' brand. His expertise lies in navigating the complex regulatory landscape of the CBD industry and building partnerships to drive revenue growth.
Historial: Under Graham Duncan's leadership, Chill Brands Group PLC has focused on expanding its product portfolio and market presence in the US, UK, and Europe. Key milestones include the rebranding from Zoetic International PLC to Chill Brands Group PLC and the launch of new CBD-infused products. However, the company continues to face challenges related to profitability and market competition.
Información del mercado OTC de CHBRF
The OTC Other tier represents the lowest tier of the OTC market, indicating that Chill Brands Group PLC may not meet the minimum financial or disclosure requirements of the higher tiers (OTCQX and OTCQB). Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited liquidity, lack of transparency, and higher risk of fraud or manipulation. This tier is generally reserved for companies with distressed financials, shell corporations, or those that choose not to comply with higher reporting standards.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited liquidity due to low trading volume.
- Lack of regulatory oversight compared to major exchanges.
- Potential for price volatility and manipulation.
- Higher risk of fraud or misrepresentation.
- Limited financial disclosure and transparency.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance and legal risks.
- Monitor trading volume and price volatility.
- Consult with a qualified financial advisor.
- Understand the risks associated with investing in OTC stocks.
- Company has a registered business address in London.
- Company has a functional website and online presence.
- Company has a CEO and management team.
- Company has been in operation since 2014.
- Company has a product portfolio of CBD-infused products.
Acciones de Chill Brands Group PLC: Preguntas Clave Respondidas
¿Cuáles son los factores clave para evaluar CHBRF?
Chill Brands Group PLC (CHBRF) actualmente tiene una puntuación IA de 38/100, indicando puntuación baja. Fortaleza clave: Established brands (Chill.com and Zoetic).. Riesgo principal a monitorear: Ongoing: Evolving regulatory landscape for CBD products in the US, UK, and Europe.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de CHBRF?
CHBRF actualmente puntúa 38/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de CHBRF?
Los precios de CHBRF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre CHBRF?
La cobertura de analistas para CHBRF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en CHBRF?
Las categorías de riesgo para CHBRF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Evolving regulatory landscape for CBD products in the US, UK, and Europe.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de CHBRF?
La relación P/E para CHBRF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está CHBRF sobrevalorada o infravalorada?
Determinar si Chill Brands Group PLC (CHBRF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de CHBRF?
Chill Brands Group PLC (CHBRF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- OTC market stocks have higher risk than exchange listed stocks.
- Financial data is limited.